Koninklijke Philips NV

Koninklijke Philips NV(PHG)股票分析

$26.720

-0.198 (-0.74%)收盤時

Loading chart…
High
26.940
Open
26.900
VWAP
26.77
Vol
531.71K
Mkt Cap
24.07B
Low
26.660
Amount
14.24M
EV/EBITDA, TTM
8.31

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

AI analysis of Koninklijke Philips NV (PHG)

hold

Given the current price of $26.72 and a low RSI of 33.39 indicating oversold conditions, Philips NV may be a candidate for a long-term hold rather than a buy. However, the recent insider selling trend of 30126.47% raises concerns about confidence in the stock's near-term prospects. The forward P/E ratio of 14.60 suggests potential value, but the overall market sentiment remains cautious due to recent downgrades by analysts.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 26.72
最低
平均
最高

UBS

2026-08-03

目標價

Neutral

Deutsche Bank

2026-07-30

目標價

Hold

JPMorgan

2026-07-29

目標價

Neutral

Citi

2026-07-01

目標價

Neutral

Morgan Stanley

2026-06-23

目標價

Equal Weight

估值指標

The current forward P/E ratio for Koninklijke Philips NV (PHG) is 14.60, compared to its 5-year average forward P/E of 15.68.

Forward P/E

Fair
5Y Average P/E
15.68
Current P/E
14.60
高估
21.55
低估
9.81

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.53
Current EV/EBITDA
8.31
高估
11.57
低估
7.49

Forward P/S

Fair
5Y Average P/S
1.16
Current P/S
1.41
高估
1.47
低估
0.86

Alphio AI Price Scenarios for PHG

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PHG

$30.22

情境價格

B

Base

Base · 50%PHG

$25.07

情境價格

B

Bear

Bear · 25%PHG

$24.03

情境價格

Whales holding PHG

E

EdgePoint Investment Group Inc.

+ HoldingPHG

+9.03%

3M Return

A

Artisan Partners Limited Partnership

+ HoldingPHG

+8.81%

3M Return

B

Bestinver Gestión, S.A. SGIIC

+ HoldingPHG

+6.39%

3M Return

M

Mondrian Investment Partners Limited

+ HoldingPHG

+5.91%

3M Return

F

Fiduciary Management, Inc.

+ HoldingPHG

+5.10%

3M Return

L

Lingotto Investment Management LLP

+ HoldingPHG

+5.04%

3M Return

PHG FAQ — answered by Alphio AI

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others. It operates in the Healthcare sector.

Given the current price of $26.72 and a low RSI of 33.39 indicating oversold conditions, Philips NV may be a candidate for a long-term hold rather than a buy. However, the recent insider selling trend of 30126.47% raises concerns about confidence in the stock's near-term prospects. The forward P/E ratio of 14.60 suggests potential value, but the overall market sentiment remains cautious due to recent downgrades by analysts.

1 analysts cover PHG: 1 rate it Buy, 0 Hold and 0 Sell.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始